Assessment of Cellular Bioenergetics in Mouse Hematopoietic Stem and Primitive Progenitor Cells using the Extracellular Flux Analyzer
September 24th, 2021
2.7K views
The method presented here summarizes optimized protocols for assessing cellular bioenergetics in non-adherent mouse hematopoietic stem and primitive progenitor cells (HSPCs) using the extracellular flux analyzer to measure the extracellular acidification rate (ECAR) and oxygen consumption rate (OCR) of HSPCs in real time.
Overview
This study presents an optimized protocol for assessing cellular bioenergetics in non-adherent mouse hematopoietic stem and progenitor cells (HSPCs). Utilizing the extracellular flux analyzer, the protocol measures extracellular acidification rate (ECAR) and oxygen consumption rate (OCR) of HSPCs in real time, providing insights into their metabolic functions.
Key Study Components
Research Area
- Metabolism of hematopoietic stem cells
- Cell bioenergetics
- High-throughput analysis
Background
- Hematopoietic stem cells undergo metabolic changes during hematopoiesis.
- The switch from glycolysis to oxidative phosphorylation is crucial for HSC function.
- This protocol can help elucidate metabolic pathways essential for HSC pluripotency.
Methods Used
- Extracellular flux analysis
- Mouse hematopoietic stem and progenitor cells
- High-throughput 96-well microplate format
Main Results
- Real-time measurement of ECAR and OCR provides insights into HSPC metabolism.
- Different responses to chemicals or genetic manipulations can be quantified.
- The methodology is adaptable for various types of suspension cells.
Conclusions
- The study demonstrates a reliable method for assessing HSPC metabolism.
- This approach holds relevance for understanding stem cell biology and therapeutic applications.
Frequently Asked Questions
What is the purpose of the protocol?
The protocol assesses cellular bioenergetics in HSPCs using real-time measurements of ECAR and OCR.
Can this method be adapted for other cell types?
Yes, the approach can be optimized for other types of suspension cells.
What key measurements does the method provide?
It provides real-time data on glycolytic and mitochondrial functions.
What technologies are utilized in this protocol?
The protocol employs an extracellular flux analyzer.
How does this method aid in understanding HSC metabolism?
It allows examination of metabolic pathways that sustain HSC pluripotency under various conditions.
Is this method suitable for high-throughput analysis?
Yes, it offers high-throughput quantification with high sensitivity.
What temperature conditions are required during the assay?
The assay involves incubation at 37 degrees Celsius in a non-carbon dioxide environment.
Executive Industry Relevance
Assessing cellular bioenergetics in hematopoietic stem and progenitor cells (HSPCs) provides critical insights into metabolic reprogramming during differentiation and stress response. Real-time measurement of extracellular acidification rate (ECAR) and oxygen consumption rate (OCR) enables mechanistic de-risking of target validation in hematopoiesis-related therapeutic areas. This approach supports predictive confidence in lead identification by linking metabolic flux to stem cell function under physiological and pathological conditions.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by quantifying glycolytic and mitochondrial flux in HSPCs under basal and stressed conditions.
- Operational Value: Supports biological de-risking through standardized assessment of metabolic switches from glycolysis to oxidative phosphorylation.
- Predictive Value: Facilitates portfolio triage by identifying compounds that modulate HSPC bioenergetics without compromising pluripotency.
Screening & Assay Development
- Scientific Value: Prepares validated suspension cell systems for downstream compound screening using real-time ECAR and OCR readouts.
- Operational Value: Ensures assay reproducibility through optimized cell seeding density, inhibitor titration, and normalization to protein content.
- Scalability: Leverages high-throughput 96-well microplate format for screening large libraries of bioenergetic modulators in HSPCs and malignant hematopoietic cells.
Translational & Preclinical Research
- Translational Continuity: Connects discovery-stage metabolic profiling to preclinical validation by modeling stress-induced metabolic shifts relevant to aging, cancer, diabetes, and obesity.
- Mechanistic De-risking: Enables evaluation of how mitochondrial dysfunction alters HSPC differentiation and maturation, informing target selection in hematologic disorders.
- Predictive Confidence: Provides quantitative thresholds for spare respiratory capacity, ATP production, and coupling efficiency to guide go/no-go decisions in lead optimization.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from target validation through lead identification to preclinical assessment by delivering functional metabolic readouts that inform stem cell-targeted therapeutic strategies.
- Discovery Biology: Supports hypothesis testing and pathway clarification by measuring basal respiration, maximal respiration, and glycolytic reserve in lineage-negative HSPCs.
- Screening: Delivers assay readiness and quantitative outputs via real-time ECAR and OCR measurements following sequential injection of glucose, oligomycin, 2-DG, FCCP, and rotenone/antimycin A.
- Analytics: Enables comparative analysis of glycolytic capacity, proton leak, and spare respiratory capacity across treatment conditions to rank compound effects on bioenergetic flux.
- Translational Research: Models disease-relevant metabolic reprogramming observed in hematopoietic stress conditions, supporting biomarker alignment in preclinical models.
- Enterprise Reuse: Establishes a reusable platform for assessing suspension cell metabolism across hematopoietic, progenitor, and malignant cell types.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation by reducing mechanistic ambiguity in HSPC metabolic regulation.
- Operational Value: Delivers standardization, reproducibility, and scalability through optimized reagent concentrations, cell attachment protocols, and data normalization workflows.
- Strategic Value: Improves go/no-go decisions by linking metabolic flux to stem cell function, reducing late-stage failure risk in hematopoiesis-modulating therapies.
- Portfolio Impact: Enables risk-adjusted prioritization of leads based on their impact on glycolytic reserve and mitochondrial coupling efficiency in HSPCs.
Implementation Considerations
- Requires expertise in primary hematopoietic stem cell isolation, extracellular flux analysis, and metabolic assay design.
- Depends on access to a Seahorse XF Analyzer, calibrant kits, and injection ports for sequential compound delivery.
- Necessitates cross-team standardization of cell preparation, seeding density, and inhibitor titration across discovery and preclinical units.
- Involves adaptation considerations for varying suspension cell types, including optimization of adhesion coating and assay medium composition.
- Practical limitations include signal variability at low cell densities and the need for careful normalization to protein content to ensure data comparability.
Biopharma FAQs
Why does null hypothesis testing matter for target validation in HSPC bioenergetics?
Null hypothesis testing ensures that observed changes in ECAR or OCR following drug treatment are statistically significant and not due to random variation. This supports confident target validation by confirming that metabolic shifts are specifically linked to pathway modulation rather than experimental noise.
How does independent variable isolation fit the discovery pipeline for metabolic screening?
Isolating independent variables such as glucose, oligomycin, or FCCP concentrations allows precise attribution of ECAR and OCR changes to specific metabolic pathways. This enables accurate structure-activity relationship mapping in lead identification campaigns targeting HSPC bioenergetics.
What quantitative dependent variable measurements enable lead optimization in hematopoietic stem cells?
Dependent variables including basal respiration, maximal respiration, glycolytic capacity, and spare respiratory capacity provide quantifiable metrics for comparing compound effects. These measurements help rank leads based on their ability to modulate metabolic flux without impairing stem cell function.
Why do replication requirements matter for cross-functional collaboration in metabolic assays?
Replication across wells and experiments ensures data reliability and comparability between discovery, screening, and preclinical teams. Consistent replication supports standardized decision-making when advancing compounds that affect HSPC glycolysis or oxidative phosphorylation.
What statistical analysis capabilities are required before implementing extracellular flux analysis in HSPC workflows?
Implementation requires the ability to normalize OCR and ECAR data to protein content, calculate derived parameters such as ATP production and coupling efficiency, and apply statistical tests to determine significance of metabolic changes. These capabilities ensure that assay outputs are robust, reproducible, and suitable for portfolio decision-making.
Chapters in this video
0:05
Introduction
1:08
Hydration of the Sensor Cartridge
2:03
Preparation of Cell-Adhesive-Coated Microplates
2:52
Seeding Cells in Cell-Adhesive-Coated Microplates
4:10
Glycolysis Stress Test Using the Extracellular Flux Analyzer
7:53
Results: Assessment of the Glycolytic Function and Mitochondrial Respiration in Mouse HSPCs
9:36
Conclusion
